Investor Day New York City
February 20, 2020 at 9:00 AM EST
SPEAKER CLIPS
-
Garo Armen, PhD - CEO
Agenus: Delivering on our Goals -
Dr. Bradley Monk, MD
Adding CTLA-4 to PD-1 in the Treatment of Advanced Cervical Cancer (Agenus Zalifrelimab and Balstilimab Interim Results) -
Anna Wijatik, MD
Agenus Clinical Development -
Jennifer Buell, PhD - President and COO
Agenus Discoveries In The Clinic -
Dr. Charles Drake, MD, PhD
Early Clinical Activity with AGEN1181 -
Dr. Tyler Curiel, MD
A Deeper Look at AGEN1181 -
Dhan Chand, PhD
Our Next Wave of Innovation -
Jennifer Buell, PhD - President and COO
Agenus Discoveries In The Clinic -
Mark Exley, PhD
AgenTus - Allogeneic Cell Therapy Approach -
Julie DeSander, MBA, SM
Smart Collaborations -
Garo Armen, PhD - CEO
Concluding Remarks